Navigation Links
Scientists Unravel Superbug That Kills in 24 Hours

Scientists have unlocked the secrets of a deadly superbug that attacks healthy young people and can kill within 24 hours.//

The news is a vital first step in attempts to find a cure for the virulent disease, PVL-MRSA, that is highly resistant to current antibiotic treatments.

Already responsible for two deaths in Britain, experts fear we are in the early stages of an epidemic that could result in a massive death toll if the superbug took hold in hospitals.

The bug generally attacks the body through open wounds and can cause necrotising pneumonia, a disease that rapidly destroys lung tissue and is lethal in 75 per cent of cases.

In 2004 it killed Richard Campbell-Smith, an 18-year-old Royal Marine, who died after scratching his legs on gorse during a training exercise in Devon. An outbreak last month at Norfolk and Norwich University hospital killed a baby and infected five others.

According to the Health Protection Agency there were 106 cases of PVL-MRSA in England and Wales in 2005 and one confirmed death from necrotising pneumonia. But researchers at the University of Texas in Houston and Lyon University in France say their new understanding of how the bug works gives them hope of heading it off before it colonises hospitals, like the basic MRSA bug before it.

Gabriela Bowden, who lead the study, told the Guardian: "We've shown that not only is PVL responsible for causing necrotising pneumonia, but it somehow also causes over-production of these other proteins which cause damage and help the infection spread.

"We now have targets to go for." Source: Bio - Bio Technology
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientists Unravel Superbug That Kills Hours

(Date:4/1/2015)... Amada Senior Care , premier provider ... opened a new office in Rocky Mount, NC – their ... Bissett decided to make the move to senior care with ... 20 years of experience in management and consulting. Their grand ... , When asked what makes Amada different from other homecare ...
(Date:4/1/2015)... TCS Healthcare Technologies (TCS), a leading ... management and population health arenas, is pleased to announce ... which is fully integrated with the ACUITY platform. , ... p.m. ET, will be led by Jeff Frater, RN, ... explore the feature-rich portal as well as the importance ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Enterprise ... 501 Global Edition, a distinguished list and report ... (MSPs). The complete 501 list is currently available ... ,     The top ranked MSPs in North America ... East and Africa ,     The top MSPs ...
(Date:3/31/2015)... 31, 2015 As the demand for ... pledging to have a mobile-friendly website online sometime during ... of Chunk Fitness’ continued commitment to bring the best ... base. All of the same great fitness information at ... be substantially easier to read while browsing on a ...
(Date:3/31/2015)... Francisco, CA (PRWEB) March 31, 2015 ... their upcoming events. The schedule for April will include ... follows: , New Student Orientation, 9-11 a.m. April 6, ... held in Room D at the Pioneer Square Campus ... & Financial Aid, 12:30-1:30 p.m. April 14, Students will ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Eastern North Carolina 2Health News:TCS Healthcare Technologies Releases Acuity Connect 2Health News:TCS Healthcare Technologies Releases Acuity Connect 3Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:ACTCM Announces April Event Schedule 2
... , ... ... ... ...
... ... the third leading cause of mortality in the U.S., according to the Centers for ... ... and costly problem. The culprit…Hospital Acquired Infections (HAIs) and they have generated much attention ...
... Previous studies have explored the effect of periodontal ... infant prematurity. In a study titled "Risk of ... lead researcher M. Jeffcott, and colleagues S. Parry ... Pennsylvania, Philadelphia) and G. Macones (Washington University, St. ...
... of the Democrats, supermajority necessary to pass comprehensive ... to promote greater efficiency in the medical delivery ... would accelerate delivery system change but would be ... congressional proposals that provide new authority for the ...
... dirty air and heart problems , THURSDAY, March 4 ... particles caused by traffic has been linked to an ... the new report, researchers analyzed data from 939 participants ... four years between 1995 and 2006. A computer model ...
... study finds that weather warmer than 75 degrees poses added ... suggests that cocaine overdose deaths in New York City go ... weekly temperature goes past 75 degrees Fahrenheit. , The ... , are based on death statistics in the city from ...
Cached Medicine News:Health News:Christiana Care Health System Wins National Award for Innovation 2Health News:Christiana Care Health System Wins National Award for Innovation 3Health News:24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination 2Health News:24x7 Infection Control, Inc. Announces World's First, Modern “Shield” Against Microbial Contamination 3Health News:Experts support new federal center for Medicare and Medicaid innovation 2Health News:Years of Exposure to Traffic Pollution Raises Blood Pressure 2
(Date:3/31/2015)... -- Accelerated orthodontic treatment will be a featured ... Annual Session, May 15-19, as seven of the ... ® . Manufactured by OrthoAccel ® Technologies, ... a FDA-cleared, Class II medical device that speeds ... percent with just 20 minutes of daily use. ...
(Date:3/31/2015)... -- SCILEX Pharmaceuticals, Inc., a company engaged in the development ... pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, ... ITOCHU Corporation ( Tokyo : 8001; OTC-PINK: ... trading companies) in Japan , has ... closely with SCILEX as an advisor and development partner ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
Breaking Medicine Technology:Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
... patients will be tested,to determine the prevalence of ... major cooperative effort between the Alpha-1 Foundation,and the ... principal investigator is Robert A. Sandhaus, MD, PhD, ... and Research Center,in Denver. Sandhaus is also the ...
... Dec. 6 DURECT Corporation,(Nasdaq: DRRX ... III trial for Remoxy,had successfully met its ... the U.S. Food and Drug Administration (FDA) ... investigational drug based on,DURECT,s patented ORADUR(TM) technology, ...
Cached Medicine Technology:Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 2Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: